These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9716932)

  • 1. Neurotransmitter transporters as molecular targets for addictive drugs.
    Amara SG; Sonders MS
    Drug Alcohol Depend; 1998; 51(1-2):87-96. PubMed ID: 9716932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Behavioral and pharmacological characteristics of mice lacking the dopamine transporter].
    Biala G
    Postepy Hig Med Dosw (Online); 2004; 58():560-4. PubMed ID: 15765018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
    Wall SC; Gu H; Rudnick G
    Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of neurotransmitter release by amphetamines: a review.
    Sulzer D; Sonders MS; Poulsen NW; Galli A
    Prog Neurobiol; 2005 Apr; 75(6):406-33. PubMed ID: 15955613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system.
    Hoffman BJ; Hansson SR; Mezey E; Palkovits M
    Front Neuroendocrinol; 1998 Jul; 19(3):187-231. PubMed ID: 9665836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines.
    Pörzgen P; Park SK; Hirsh J; Sonders MS; Amara SG
    Mol Pharmacol; 2001 Jan; 59(1):83-95. PubMed ID: 11125028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychostimulants and monoamine transporters: upsetting the balance.
    Elliott JM; Beveridge TJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):94-100. PubMed ID: 15661632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships at monoamine transporters and muscarinic receptors for N-substituted-3alpha-(3'-chloro-, 4'-chloro-, and 4',4''-dichloro-substituted-diphenyl)methoxytropanes.
    Newman AH; Robarge MJ; Howard IM; Wittkopp SL; George C; Kopajtic T; Izenwasser S; Katz JL
    J Med Chem; 2001 Feb; 44(4):633-40. PubMed ID: 11170654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.
    Sora I; Hall FS; Andrews AM; Itokawa M; Li XF; Wei HB; Wichems C; Lesch KP; Murphy DL; Uhl GR
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5300-5. PubMed ID: 11320258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroadaptations involved in amphetamine and cocaine addiction.
    White FJ; Kalivas PW
    Drug Alcohol Depend; 1998; 51(1-2):141-53. PubMed ID: 9716936
    [No Abstract]   [Full Text] [Related]  

  • 11. The dopamine transporter: a crucial component regulating dopamine transmission.
    Jaber M; Jones S; Giros B; Caron MG
    Mov Disord; 1997 Sep; 12(5):629-33. PubMed ID: 9380041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.
    Fleckenstein AE; Gibb JW; Hanson GR
    Eur J Pharmacol; 2000 Oct; 406(1):1-13. PubMed ID: 11011026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dopamine control of neuroendocrine functions. New findings based on the study of transgenic animals].
    Jaber M
    Ann Endocrinol (Paris); 1997; 58(6):427-35. PubMed ID: 9686001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of morphine on locomotor activity and striatal monoamine metabolism in nicotine-withdrawn mice.
    Vihavainen T; Mijatovic J; Piepponen TP; Tuominen RK; Ahtee L
    Behav Brain Res; 2006 Oct; 173(1):85-93. PubMed ID: 16846651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine responsiveness to drugs of abuse: A shell-core investigation in the nucleus accumbens of the mouse.
    Zocchi A; Girlanda E; Varnier G; Sartori I; Zanetti L; Wildish GA; Lennon M; Mugnaini M; Heidbreder CA
    Synapse; 2003 Dec; 50(4):293-302. PubMed ID: 14556234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine transporter pharmacology and mutant mice.
    Gainetdinov RR; Sotnikova TD; Caron MG
    Trends Pharmacol Sci; 2002 Aug; 23(8):367-73. PubMed ID: 12377578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced cocaine-induced serotonin, but not dopamine and noradrenaline, release in rats with a genetic deletion of serotonin transporters.
    Verheij MM; Karel P; Cools AR; Homberg JR
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1850-4. PubMed ID: 25261262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters.
    Rudnick G; Wall SC
    Mol Pharmacol; 1993 Feb; 43(2):271-6. PubMed ID: 8429828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter.
    Jayanthi LD; Apparsundaram S; Malone MD; Ward E; Miller DM; Eppler M; Blakely RD
    Mol Pharmacol; 1998 Oct; 54(4):601-9. PubMed ID: 9765501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.
    Rickli A; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):365-76. PubMed ID: 25624004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.